Rucaparib Impurity 12 | CAS 2331277-14-4 - Request Quote
Rucaparib Impurity 12
| SZ CAT No: | SZ-R055014 |
| CAS No | 2331277-14-4 |
| Mol.F. | C20H12FNO4 |
| Mol.Wt. | 349.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rucaparib Impurity 12 is chemically 2-(8-fluoro-1-oxo-1,3,4,6-tetrahydrooxepino[5,4,3-cd]indol-3-yl)-1H-indene-1,3(2H)-dione. Rucaparib Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Rucaparib Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rucaparib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2331277-14-4
Purchase 2331277-14-4
Order 2331277-14-4
Enquire 2331277-14-4
price of 2331277-14-4
2331277-14-4 Supplier
2331277-14-4 Manufacturer
2331277-14-4 Exporter
buy high quality Rucaparib Impurity 12
Purchase Rucaparib Impurity 12
Rucaparib Impurity 12 suppliers
Rucaparib Impurity 12 manufacturers
Rucaparib Impurity 12 price
Order Rucaparib Impurity 12
Enquire Rucaparib Impurity 12
Rucaparib Impurity 12 cost
Rucaparib Impurity 12 Supplier
Rucaparib Impurity 12 Distributor
Rucaparib Impurity 12 for Method Validation
Rucaparib Reference Standard
Rucaparib Impurity 12 for ANDA Filing
Rucaparib Impurity 12 for Forced Degradation Studies
Rucaparib Impurity 12 Identification Standards
Rucaparib Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


